C.R. Bard Leg Bag Recall: Potential Sterile Barrier Breach Risk
C.R. Bard recalls leg bags with flip-flo valve that may have cuts in the sterile barrier, risking infection. Check product code 151919 for affected units.
Lower-risk recall
Customer complaint of a cut in the side of the leg bag, indicating a potential breach of the product's sterile barrier.
Contact the company
What happened, in plain English
C.R. Bard is recalling leg bags that may have cuts in the sterile barrier, which could lead to infection. This recall affects medical users who rely on these bags for catheter drainage. Read more at govinfonow.com/recall/73972-c-r-bard-leg-bag-recall-potential-sterile-barrier-breach.
Source Summary by GovInfoNow · govinfonow.com/recall/73972-c-r-bard-leg-bag-recall-potential-sterile-barrier-breach · Updated September 23, 2026 · FDA enforcement record: FDA #Z-2872-2017
Cite this page
“C.R. Bard Leg Bag Recall: Potential Sterile Barrier Breach Risk.” GovInfoNow, updated September 23, 2026. https://govinfonow.com/recall/73972-c-r-bard-leg-bag-recall-potential-sterile-barrier-breach. Based on FDA recall #Z-2872-2017 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-2872-2017%22&limit=1).
Why it’s dangerous
The leg bag's sterile barrier may have cuts, potentially allowing bacteria to enter the body. This could lead to infection if the bag is used without a breach.
Who’s affected
Medical users who apply these leg bags for urinary catheters are most at risk. The recall targets patients using the product for bladder management.
How to tell if you have this one
Check for product code 151919 on the bag. The bag is packaged in thermoformed trays with 50 units per case.
- Brand
C.R. Bard- Category
Medical device
What to do — step by step
Check Product Code
Look for product code 151919 on the leg bag packaging.
Where it went and when
Where it was distributed
Distributed nationwide; the notice names 16 states.
FDA distribution: “US Nationwide in the states of CA, CO, FL, IL, IN, LA, MN, MO, NC, NJ, NY, OH, OK, PA, TX, WY, including PR.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Named in the notice: California, Colorado, Florida, Illinois, Indiana, Louisiana, Minnesota, Missouri, New Jersey, New York, North Carolina, Ohio, Oklahoma, Pennsylvania, Puerto Rico, Texas, Wyoming.
Recall timeline
FDA terminated this recall 4.1 years after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest medical device recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #Z-2872-2017 (June 2, 2017) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-2872-2017 to see it in context.
- Plain-language summary written by qwen3:4b on September 23, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.